Online Exclusives

Online Exclusives

Conference Coverage: ELOQUENT-2: Adding Elotuzumab to Standard Therapy Reduces Progression Risk for Multiple Myeloma...

CHICAGO—According to interim results of the phase III, randomized, open-label ELOQUENT-2 study, elotuzumab may offer a new treatment option for patients with relapsed multiple...

EMA Recommends Conditional Approval for Daratumumab

The European Medicines Agency (EMA) has recommended the approval of daratumumab for adult patients with multiple myeloma who have already failed standard treatment. This...

JCAR015 Trial Temporarily Put on Clinical Hold by FDA, Then Allowed to Resume

After the U.S. Food and Drug Administration (FDA) placed a phase II chimeric antigen receptor (CAR) trial on clinical hold due to patient deaths,...

NHLBI to Provide Funding Opportunities to Advance Hematopoietic Cell Transplantation

The National Heart, Lung, and Blood Institute (NHLBI) released a notice stating its intention to publish funding opportunities and solicit applications for the Data...

Researchers Develop a “Smart” Skin Patch to Detect Thrombosis in Mice

According to a study published in Advanced Materials, a thrombin-responsive, closed-loop skin patch can detect thrombosis and release the required amounts of anticoagulation to...

European Commission Approves Elotuzumab for Multiple Myeloma

The European Commission approved elotuzumab in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma (MM) in patients who have received at...

Researchers Identify 11 Different Subtypes of Acute Myeloid Leukemia

In an analysis of more than 100 genes known to cause acute myeloid leukemia (AML), researchers from the Memorial Sloan Kettering Cancer Center in...

Study Finds That Hemophilia B Is Clinically Less Severe Than Hemophilia A

Though hemophilia A and B are traditionally considered clinically indistinguishable, a study published in Blood Transfusion suggests that severe hemophilia B (factor IX deficiency)...

Alemtuzumab Improves Survival in Patients With Chronic Lymphocytic Leukemia

An open-label, phase II study published in the British Journal of Haematology found that, in patients with chronic lymphocytic leukemia (CLL) who achieved negative...

Use of Mogamulizumab Cautioned in Patients With T-Cell Leukemia and Lymphoma due to Increased...

Adult patients with T-cell lymphoma and leukemia (ATLL) who were treated with mogamulizumab prior to allogeneic hematopoietic cell transplantation (alloHCT) experienced significantly more grade...
Advertisement

Current Issue

May 2019, Volume 5, Issue 6

This issue features a look at home-based care for hematologic disorders, strides in pediatric leukemia in El Salvador, and more.